Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capital Bancorp (CBNK) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Capital Bancorp (CBNK) over the last 9 years, with Q3 2025 value amounting to $188.9 million.

  • Capital Bancorp's Cash & Equivalents rose 2052.39% to $188.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.9 million, marking a year-over-year increase of 2052.39%. This contributed to the annual value of $205.3 million for FY2024, which is 28049.81% up from last year.
  • According to the latest figures from Q3 2018, Capital Bancorp's Revenue - Interest and Investment Income is $1.1 billion, which was up 757.13% from $1.0 billion recorded in Q4 2017.
  • Over the past 5 years, Capital Bancorp's Cash & Equivalents peaked at $324.0 million during Q3 2021, and registered a low of $37.1 million during Q3 2022.
  • Its 5-year average for Cash & Equivalents is $190.4 million, with a median of $183.4 million in 2021.
  • The largest annual percentage gain for Capital Bancorp's Revenue - Interest and Investment Income in the last 5 years was 757.13% (2018), contrasted with its biggest fall of 757.13% (2018).
  • Capital Bancorp's Revenue - Interest and Investment Income (Quarter) stood at $1.0 billion in 2017, then increased by 4.57% to $1.1 billion in 2018.
  • Its Cash & Equivalents was $188.9 million in Q3 2025, compared to $274.6 million in Q2 2025 and $294.0 million in Q1 2025.